Chemotherapeutic antibiotic
This page covers all Chemotherapeutic antibiotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DNA.
Targets
Phase 3 pipeline (1)
- Bleomycin Sulfate (BLM) · M.D. Anderson Cancer Center · Oncology
Bleomycin is a chemotherapeutic antibiotic that binds to DNA and causes strand breaks, leading to cell death.
Patent intelligence
- chemotherapeutic antibiotic patent landscape — aggregated cliff calendar, attackable patents, originator estates